Cargando…

Diagnostic Values of the QuantiFERON-TB Gold In-Tube Assay Carried out in China for Diagnosing Pulmonary Tuberculosis

BACKGROUND: Interferon-release assays (IGRAs) for diagnosing active pulmonary tuberculosis (PTB) are not yet fully validated, particularly in high TB-endemic areas as the People's Republic of China (PRC). The aim of this report was to assess the performance of the QuantiFERON-TB Gold In-tube (Q...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Hui, Wang, Xiaomen, Li, Fabin, Longuet, Christophe, Vernet, Guy, Goletti, Delia, Zhao, Yanlin, Lagrange, Philippe H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395092/
https://www.ncbi.nlm.nih.gov/pubmed/25867946
http://dx.doi.org/10.1371/journal.pone.0121021
_version_ 1782366367841779712
author Xia, Hui
Wang, Xiaomen
Li, Fabin
Longuet, Christophe
Vernet, Guy
Goletti, Delia
Zhao, Yanlin
Lagrange, Philippe H.
author_facet Xia, Hui
Wang, Xiaomen
Li, Fabin
Longuet, Christophe
Vernet, Guy
Goletti, Delia
Zhao, Yanlin
Lagrange, Philippe H.
author_sort Xia, Hui
collection PubMed
description BACKGROUND: Interferon-release assays (IGRAs) for diagnosing active pulmonary tuberculosis (PTB) are not yet fully validated, particularly in high TB-endemic areas as the People's Republic of China (PRC). The aim of this report was to assess the performance of the QuantiFERON-TB Gold In-tube (QFT-GIT) and tuberculin skin test (TST), in addition to microbiological results, as contributors for diagnosing active PTB in the PRC. METHODS/PRINCIPAL FINDINGS: A total of 300 PTB patients, 41 disease controls (DC) and 59 healthy community controls (HCC) were included prospectively between May 2010 and April 2011 from two provinces of the PRC (Heilongjiang and Zhejiang). The QFT-GIT and TST yielded an overall sensitivity for active TB of 80.9% and 86.2%, and a specificity of 36.6% and 26.8%, respectively. The province of origin and smear microscopy status did not significantly impact the diagnostic values for PTB. However, using the TST with a 10 mm cut-off point, a significantly higher proportion of LTBI was observed in the DC than the HCC (p=0.01). Discordant results between the QFT-GIT and TST were found among 1/3 of the PTB, HCC and DC. Two-thirds of the individuals presented TST-positive/QFT-GIT-negative discordant results. The TST-negative/QFT-GIT-positive result was not associated with age or bacillary load. Cumulative QFT-GIT and TST positive results increased the overall sensitivity (95.9%), but it was associated with a dramatic decrease of the overall specificity (24.8%) leading to a suboptimal PPV (80.1%) and a low NPV (61.1%). CONCLUSIONS/SIGNIFICANCE: The usefulness of the QFT-GIT to diagnose active TB in high TB-endemic countries remains doubtful because like the TST, the QFT-GIT cannot distinguish between LTBI and active TB. Used as single stand-alone tests, both the QFT-GIT and TST have very limited roles in the diagnosis of active PTB. However, the combined use of SM, the TST and QFT-GIT may allow for the exclusion of ATB.
format Online
Article
Text
id pubmed-4395092
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43950922015-04-21 Diagnostic Values of the QuantiFERON-TB Gold In-Tube Assay Carried out in China for Diagnosing Pulmonary Tuberculosis Xia, Hui Wang, Xiaomen Li, Fabin Longuet, Christophe Vernet, Guy Goletti, Delia Zhao, Yanlin Lagrange, Philippe H. PLoS One Research Article BACKGROUND: Interferon-release assays (IGRAs) for diagnosing active pulmonary tuberculosis (PTB) are not yet fully validated, particularly in high TB-endemic areas as the People's Republic of China (PRC). The aim of this report was to assess the performance of the QuantiFERON-TB Gold In-tube (QFT-GIT) and tuberculin skin test (TST), in addition to microbiological results, as contributors for diagnosing active PTB in the PRC. METHODS/PRINCIPAL FINDINGS: A total of 300 PTB patients, 41 disease controls (DC) and 59 healthy community controls (HCC) were included prospectively between May 2010 and April 2011 from two provinces of the PRC (Heilongjiang and Zhejiang). The QFT-GIT and TST yielded an overall sensitivity for active TB of 80.9% and 86.2%, and a specificity of 36.6% and 26.8%, respectively. The province of origin and smear microscopy status did not significantly impact the diagnostic values for PTB. However, using the TST with a 10 mm cut-off point, a significantly higher proportion of LTBI was observed in the DC than the HCC (p=0.01). Discordant results between the QFT-GIT and TST were found among 1/3 of the PTB, HCC and DC. Two-thirds of the individuals presented TST-positive/QFT-GIT-negative discordant results. The TST-negative/QFT-GIT-positive result was not associated with age or bacillary load. Cumulative QFT-GIT and TST positive results increased the overall sensitivity (95.9%), but it was associated with a dramatic decrease of the overall specificity (24.8%) leading to a suboptimal PPV (80.1%) and a low NPV (61.1%). CONCLUSIONS/SIGNIFICANCE: The usefulness of the QFT-GIT to diagnose active TB in high TB-endemic countries remains doubtful because like the TST, the QFT-GIT cannot distinguish between LTBI and active TB. Used as single stand-alone tests, both the QFT-GIT and TST have very limited roles in the diagnosis of active PTB. However, the combined use of SM, the TST and QFT-GIT may allow for the exclusion of ATB. Public Library of Science 2015-04-13 /pmc/articles/PMC4395092/ /pubmed/25867946 http://dx.doi.org/10.1371/journal.pone.0121021 Text en © 2015 Xia et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Xia, Hui
Wang, Xiaomen
Li, Fabin
Longuet, Christophe
Vernet, Guy
Goletti, Delia
Zhao, Yanlin
Lagrange, Philippe H.
Diagnostic Values of the QuantiFERON-TB Gold In-Tube Assay Carried out in China for Diagnosing Pulmonary Tuberculosis
title Diagnostic Values of the QuantiFERON-TB Gold In-Tube Assay Carried out in China for Diagnosing Pulmonary Tuberculosis
title_full Diagnostic Values of the QuantiFERON-TB Gold In-Tube Assay Carried out in China for Diagnosing Pulmonary Tuberculosis
title_fullStr Diagnostic Values of the QuantiFERON-TB Gold In-Tube Assay Carried out in China for Diagnosing Pulmonary Tuberculosis
title_full_unstemmed Diagnostic Values of the QuantiFERON-TB Gold In-Tube Assay Carried out in China for Diagnosing Pulmonary Tuberculosis
title_short Diagnostic Values of the QuantiFERON-TB Gold In-Tube Assay Carried out in China for Diagnosing Pulmonary Tuberculosis
title_sort diagnostic values of the quantiferon-tb gold in-tube assay carried out in china for diagnosing pulmonary tuberculosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395092/
https://www.ncbi.nlm.nih.gov/pubmed/25867946
http://dx.doi.org/10.1371/journal.pone.0121021
work_keys_str_mv AT xiahui diagnosticvaluesofthequantiferontbgoldintubeassaycarriedoutinchinafordiagnosingpulmonarytuberculosis
AT wangxiaomen diagnosticvaluesofthequantiferontbgoldintubeassaycarriedoutinchinafordiagnosingpulmonarytuberculosis
AT lifabin diagnosticvaluesofthequantiferontbgoldintubeassaycarriedoutinchinafordiagnosingpulmonarytuberculosis
AT longuetchristophe diagnosticvaluesofthequantiferontbgoldintubeassaycarriedoutinchinafordiagnosingpulmonarytuberculosis
AT vernetguy diagnosticvaluesofthequantiferontbgoldintubeassaycarriedoutinchinafordiagnosingpulmonarytuberculosis
AT golettidelia diagnosticvaluesofthequantiferontbgoldintubeassaycarriedoutinchinafordiagnosingpulmonarytuberculosis
AT zhaoyanlin diagnosticvaluesofthequantiferontbgoldintubeassaycarriedoutinchinafordiagnosingpulmonarytuberculosis
AT lagrangephilippeh diagnosticvaluesofthequantiferontbgoldintubeassaycarriedoutinchinafordiagnosingpulmonarytuberculosis